These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36551743)

  • 1. Impact of Mobilization Strategies on Peripheral Blood Stem Cell Collection Efficiency and Product Quality: A Retrospective Single-Center Study.
    Rajsp P; Branka M; Besson N; Tanzmann A; Worel N
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures.
    Sanderson F; Poullin P; Smith R; Nicolino-Brunet C; Philip P; Chaib A; Costello R
    J Clin Apher; 2017 Jun; 32(3):182-190. PubMed ID: 27442837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three mobilization protocols for peripheral blood stem cell apheresis with Spectra Optia continuous mononuclear cell protocol in healthy dogs.
    Kim S; Hosoya K; Kobayashi A; Okumura M
    Vet Comp Oncol; 2019 Mar; 17(1):61-68. PubMed ID: 30221450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells-apheresis (HPC-a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study.
    Pandey S; Cottler-Fox M
    J Clin Apher; 2018 Aug; 33(4):505-513. PubMed ID: 29603795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of two different cell separators for autologous peripheral blood stem cell collection: Single center experience.
    Keklik M
    Hematol Transfus Cell Ther; 2024; 46(4):335-339. PubMed ID: 37085345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience.
    Solmaz S; Kahraman S; Sevindik OG; Acar C; Turkyilmaz M; Alacacioglu I; Piskin O; Ozcan MA; Ozsan HG; Undar B; Demirkan F
    Indian J Hematol Blood Transfus; 2018 Oct; 34(4):677-683. PubMed ID: 30369740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection.
    Chung Y; Kong JH; Hu Y; Lee SN; Shim H; Eom HS; Kong SY
    J Clin Apher; 2021 Feb; 36(1):28-33. PubMed ID: 32882095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous CD34+ cell collection by a new device is safe and more efficient than by a standard collection procedure: results of a two-center, crossover, randomized trial.
    Cancelas JA; Scott EP; Bill JR
    Transfusion; 2016 Nov; 56(11):2824-2832. PubMed ID: 27589225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems.
    Brauninger S; Bialleck H; Thorausch K; Felt T; Seifried E; Bonig H
    Transfusion; 2012 May; 52(5):1137-45. PubMed ID: 22044384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new protocol for improving efficiency of autologous peripheral blood stem cell collection in patients with high white blood cell counts.
    Boehlen R; Fernandez P; Bargetzi M; Sigle JP
    J Clin Apher; 2020 Jun; 35(3):217-223. PubMed ID: 32304598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
    Ishii A; Jo T; Arai Y; Oshima S; Kanda J; Kitawaki T; Matsui K; Niwa N; Nakagawa Y; Takaori-Kondo A; Nagao M
    Cytotherapy; 2022 Jan; 24(1):49-58. PubMed ID: 34654641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
    Long G; Waller EK; Gregurek S; Tricot G; Marschner S; Bill J
    J Clin Apher; 2015 Feb; 30(1):1-7. PubMed ID: 24941931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center.
    López-Pereira P; Sola Aparicio E; Vicuña Andrés I; Cámara Montejano C; Muñoz Calleja C; Alegre Amor A; Aguado Bueno B
    J Clin Apher; 2020 Sep; 35(5):453-459. PubMed ID: 32798328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CD34+ pre-counting and plerixafor on autologous peripheral blood stem cell collection in Japanese university hospitals in eight years.
    Nakamura Y; Okubo M; Furuta Y; Tokida M; Ichikawa K; Ohsaka A
    Transfus Apher Sci; 2019 Dec; 58(6):102664. PubMed ID: 31753774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low hematocrit reduces the efficiency of CD34
    Kondo T; Fujii N; Fujii K; Sumii Y; Urata T; Kimura M; Matsuda M; Ikegawa S; Washio K; Fujiwara H; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Otsuka F; Maeda Y
    Transfusion; 2022 May; 62(5):1065-1072. PubMed ID: 35322885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between intermittent and continuous spectra optia leukapheresis systems for autologous peripheral blood stem cell collection.
    Lisenko K; Pavel P; Bruckner T; Puthenparambil J; Hundemer M; Schmitt A; Witzens-Harig M; Ho AD; Wuchter P
    J Clin Apher; 2017 Feb; 32(1):27-34. PubMed ID: 27095367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.
    Micallef IN; Sinha S; Gastineau DA; Wolf R; Inwards DJ; Gertz MA; Hayman SR; Hogan WJ; Johnston PB; Lacy MQ; Ansell SM; Buadi F; Dingli D; Dispenzieri A; Litzow MR; Porrata LF; Winters JL; Kumar S
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):87-93. PubMed ID: 22922211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of apheresis automation on procedure quality and predictability of CD34
    Besson N; Topholm Bruun M; Stauffer Larsen T; Nielsen C
    J Clin Apher; 2018 Aug; 33(4):494-504. PubMed ID: 29570217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and equipment-related factors associated with the adequate peripheral blood stem cell collection in autologous transplant at a tertiary cancer center in Kerala - A retrospective cohort study.
    Murugesan M; Shringarpure K; Karthickeyan DSA; Nair CK; Nayanar SK; Venugopal V; Selvaraj K; Rathi P; Mehta KG; Deenathayalan V; Gayathiri KC
    Transfus Apher Sci; 2019 Aug; 58(4):457-463. PubMed ID: 31255504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.
    Stover JT; Shaw JR; Kuchibhatla M; Horwitz ME; Engemann AM
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1290-1294. PubMed ID: 28411174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.